awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33442621-0853DE6F-E8A8-4A21-855C-018E15D1A1F3
Q33442621-0853DE6F-E8A8-4A21-855C-018E15D1A1F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442621-0853DE6F-E8A8-4A21-855C-018E15D1A1F3
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
P2860
Q33442621-0853DE6F-E8A8-4A21-855C-018E15D1A1F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33442621-0853DE6F-E8A8-4A21-855C-018E15D1A1F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25ee20e77fdc977324982409d6413d76ae3cbf87
P2860
Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma.